Your browser doesn't support javascript.
loading
The CD44/COL17A1 pathway promotes the formation of multilayered, transformed epithelia.
Kozawa, Kei; Sekai, Miho; Ohba, Kenji; Ito, Shoko; Sako, Hiroaki; Maruyama, Takeshi; Kakeno, Mai; Shirai, Takanobu; Kuromiya, Keisuke; Kamasaki, Tomoko; Kohashi, Koki; Tanaka, Shinya; Ishikawa, Susumu; Sato, Nanami; Asano, Shota; Suzuki, Hironori; Tanimura, Nobuyuki; Mukai, Yohei; Gotoh, Noriko; Tanino, Mishie; Tanaka, Shinya; Natsuga, Ken; Soga, Tomoyoshi; Nakamura, Tomonori; Yabuta, Yukihiro; Saitou, Mitinori; Ito, Takahiro; Matsuura, Kenkyo; Tsunoda, Makoto; Kikumori, Toyone; Iida, Tadashi; Mizutani, Yasuyuki; Miyai, Yuki; Kaibuchi, Kozo; Enomoto, Atsushi; Fujita, Yasuyuki.
Afiliación
  • Kozawa K; Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Department of Cell Pharmacology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University Graduate School of Chemical
  • Sekai M; Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan; KAN Research Institute, Inc., Kobe, Japan.
  • Ohba K; KAN Research Institute, Inc., Kobe, Japan; Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University Graduate School of Chemical Sciences and Engineering, Sapporo, Japan.
  • Ito S; Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan; KAN Research Institute, Inc., Kobe, Japan.
  • Sako H; Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan; KAN Research Institute, Inc., Kobe, Japan.
  • Maruyama T; KAN Research Institute, Inc., Kobe, Japan; Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University Graduate School of Chemical Sciences and Engineering, Sapporo, Japan.
  • Kakeno M; KAN Research Institute, Inc., Kobe, Japan; Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University Graduate School of Chemical Sciences and Engineering, Sapporo, Japan.
  • Shirai T; Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University Graduate School of Chemical Sciences and Engineering, Sapporo, Japan.
  • Kuromiya K; Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University Graduate School of Chemical Sciences and Engineering, Sapporo, Japan.
  • Kamasaki T; Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University Graduate School of Chemical Sciences and Engineering, Sapporo, Japan.
  • Kohashi K; Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University Graduate School of Chemical Sciences and Engineering, Sapporo, Japan.
  • Tanaka S; Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University Graduate School of Chemical Sciences and Engineering, Sapporo, Japan.
  • Ishikawa S; Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University Graduate School of Chemical Sciences and Engineering, Sapporo, Japan.
  • Sato N; Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University Graduate School of Chemical Sciences and Engineering, Sapporo, Japan.
  • Asano S; Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Suzuki H; Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Tanimura N; Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University Graduate School of Chemical Sciences and Engineering, Sapporo, Japan.
  • Mukai Y; KAN Research Institute, Inc., Kobe, Japan.
  • Gotoh N; Division of Cancer Cell Biology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Tanino M; Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan; Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Japan.
  • Tanaka S; Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan; Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Japan.
  • Natsuga K; Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Soga T; Institute for Advanced Biosciences, Keio University, Tsuruoka, Japan.
  • Nakamura T; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan; Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Yabuta Y; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan; Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Saitou M; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan; Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Ito T; Division of Cell Fate Dynamics and Therapeutics, Department of Biosystems Science, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Matsuura K; Division of Cell Fate Dynamics and Therapeutics, Department of Biosystems Science, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Tsunoda M; Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
  • Kikumori T; Department of Breast and Endocrine Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Iida T; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Mizutani Y; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Miyai Y; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kaibuchi K; Department of Cell Pharmacology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Institute for Comprehensive Medical Science (ICMS), Fujita Health University, Toyoake, Japan.
  • Enomoto A; Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Fujita Y; Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University Graduate School of Chemical Sciences and Engineering, Sapporo, Japan. Electronic address: fujita@monc.med.kyoto-u.ac.jp.
Curr Biol ; 31(14): 3086-3097.e7, 2021 07 26.
Article en En | MEDLINE | ID: mdl-34087104
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Transformación Celular Neoplásica / Receptores de Hialuranos / Colágenos no Fibrilares / Epitelio Tipo de estudio: Screening_studies Límite: Animals / Humans Idioma: En Revista: Curr Biol Asunto de la revista: BIOLOGIA Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Transformación Celular Neoplásica / Receptores de Hialuranos / Colágenos no Fibrilares / Epitelio Tipo de estudio: Screening_studies Límite: Animals / Humans Idioma: En Revista: Curr Biol Asunto de la revista: BIOLOGIA Año: 2021 Tipo del documento: Article